Tamoxifen Completed Phase 4 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02344940Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer
NCT01612871Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer
NCT01553903Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not